Complement inhibition with Eculizumab affects fibrinogen levels and clot Structure in patients with Paroxysmal Nocturnal Haemoglobinuria

被引：0
|
作者：
Macrae, F. [1 ]
Bowman, P. [1 ]
Linton, E. [1 ]
Peacock-Young, B. [1 ]
Clarke, D. [2 ]
Newton, D. [2 ]
McKinley, C. [2 ]
Riley, K. [3 ]
Copeland, N. [3 ]
Arnold, L. [2 ]
Ariens, R. [1 ]
Hill, A. [3 ]
机构：
[1] LIGHT Labs Leeds, Div Cardiovasc & Diabet Res, Leeds, W Yorkshire, England
[2] Univ Leeds, Sect Expt Haematol, Leeds, W Yorkshire, England
[3] Leeds Teaching Hosp, Dept Haematol, Leeds, W Yorkshire, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷
关键词：
clotting; eculizumab; fibrinogen; paroxysmal nocturnal haemoglobinuria; thrombosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH18-PO-1
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [1] Fibrinogen and Clot Structure Is Affected By Eculizumab in Patients with Paroxysmal Nocturnal Haemoglobinuria
    Macrae, Fraser
    Bowman, Polly
    Linton, Emma
    Peacock-Young, Barnaby
    Clarke, Deborah
    Newton, Darren J.
    McKinley, Claire E.
    Riley, Kathryn
    Copeland, Nicola
    Arnold, Louise
    Griffin, Morag
    Munir, Talha
    Hillmen, Peter
    Richards, Stephen John
    Ariens, Robert
    Hill, Anita
    [J]. BLOOD, 2017, 130
  • [2] Complement assessment in patients with paroxysmal nocturnal haemoglobinuria treated by eculizumab
    de Latour, R. Peffault
    Fremeaux-Bacchi, V.
    Porcher, R.
    Rodriguez-Otero, P.
    Abbes, S.
    Roncelin, S.
    Socie, G.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S414 - S415
  • [3] Eculizumab in paroxysmal nocturnal haemoglobinuria
    Escudero-Jimenez, Angel
    Jesus Esteban-Mensua, Maria
    Lopez-Briz, Eduardo
    Jarque-Ramos, Isidro
    Borrell-Garcia, Carmela
    Luis Poveda-Andres, Jose
    [J]. EJHP PRACTICE, 2011, 17 (01): : 31 - 35
  • [4] Eculizumab in paroxysmal nocturnal haemoglobinuria
    Charneski, Lisa
    Patel, Priti N.
    [J]. DRUGS, 2008, 68 (10) : 1341 - 1346
  • [5] Eculizumab for paroxysmal nocturnal haemoglobinuria
    Parker, Charles
    [J]. LANCET, 2009, 373 (9665): : 759 - 767
  • [6] Eculizumab in Paroxysmal Nocturnal Haemoglobinuria
    Lisa Charneski
    Priti N. Patel
    [J]. Drugs, 2008, 68 : 1341 - 1346
  • [7] Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria
    Schubert, Joerg
    Hillmen, Peter
    Roeth, Alexander
    Young, Neal S.
    Elebute, Modupe O.
    Szer, Jeffery
    Gianfaldoni, Giacomo
    Socie, Gerard
    Browne, Paul
    Geller, Robert
    Rother, Russel P.
    Muus, Petra
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (02) : 263 - 272
  • [8] The terminal complement inhibitor eculizumab reduces thrombosis in patients with paroxysmal nocturnal haemoglobinuria
    Hillmen, P.
    Hill, A.
    Muus, P.
    Duhrsen, U.
    Risitano, A. M.
    Schubert, J.
    Young, N. S.
    Schrezenmeier, H.
    Szer, J.
    Brodsky, R. A.
    Socie, G.
    Rollins, S. A.
    Rother, R. P.
    Bell, L.
    Luzzatto, L.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 34 - 34
  • [9] With paroxysmal nocturnal haemoglobinuria and treatment with eculizumab
    Tomas Algado, Jose
    Luque, Rafael
    Nunez, Ramiro
    Sanchez, Berta
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2012, 30 (02): : 109 - 110
  • [10] Antiphospholipid antibodies in patients with paroxysmal nocturnal haemoglobinuria receiving eculizumab
    Darnige, Luc
    de Latour, Regis Peffault
    Zemori, Laurence
    Socie, Gerard
    Fischer, Anne-Marie
    Helley, Dominique
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (06) : 789 - 791
12345